Literature DB >> 3522225

Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.

R W Vreede, J Leuvenink, A S Bouter, E C Brouwer, J H Marcelis, J Verhoef.   

Abstract

Six monoclonal antibodies raised against Escherichia coli O111 and against its rough mutant J5 (chemotype Rc) were studied. One IgG2A, one IgM anti-J5, and one IgG2A anti-O111 monoclonal antibody did not bind to lipopolysaccharides of the homologous strain, but cross-reacted with heterologous gram-negative rods in an enzyme-linked immunosorbent assay. These three monoclonal antibodies activated complement when incubated with homologous or heterologous strains, but were opsonic neither in the presence nor in the absence of complement. The other three monoclonal antibodies were directed against lipopolysaccharide of the homologous strain, but showed no cross-reactivity. The IgG3 and one IgM anti-J5 monoclonal antibodies activated complement and were opsonic only in the presence of complement. The IgM anti-O111 monoclonal antibody activated complement and was opsonic both in the presence and absence of complement. Thus, the outcome of the interaction between bacteria, antibodies, and complement is influenced primarily by whether antibodies are directed against lipopolysaccharides or against other cell wall components.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3522225     DOI: 10.1007/bf02013969

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  26 in total

1.  Passive immunization against the local Shwartzman reaction.

Authors:  A I Braude; H Douglas
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

4.  Functional role of antibody against "core" glycolipid of Enterobacteriaceae.

Authors:  L S Young; P Stevens; J Ingram
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

5.  Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria.

Authors:  J Verhoef; P K Peterson; P G Quie
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

6.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

Review 7.  Production of monoclonal antibodies: strategy and tactics.

Authors:  S F de StGroth; D Scheidegger
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

8.  The treatment of gram-negative bacteremia and shock.

Authors:  S M Wolff
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

9.  Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.

Authors:  W R McCabe
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

10.  Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.

Authors:  M I Marks; E J Ziegler; H Douglas; L B Corbeil; A I Braude
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

View more
  2 in total

1.  Role of antibodies in the opsonization of Yersinia spp.

Authors:  R Tertti; E Eerola; K Granfors; R Lahesmaa-Rantala; K Pekkola-Heino; A Toivanen
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

2.  Local immunization impacts the response of dairy cows to Escherichia coli mastitis.

Authors:  Vincent Herry; Christophe Gitton; Guillaume Tabouret; Maryline Répérant; Laurine Forge; Christian Tasca; Florence B Gilbert; Edouard Guitton; Céline Barc; Christophe Staub; David G E Smith; Pierre Germon; Gilles Foucras; Pascal Rainard
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.